Selexis Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Selexis General Information

Description

Operator of a life science company intended to develop cell line generation technologies that improve the expression of recombinant proteins in mammalian cells. The company's cell line generation technologies develop mammalian biopharmaceuticals for the production of monoclonal antibodies and recombinant proteins, thereby enabling scientists and biopharmaceutical companies to translate scientific innovation into life-saving medicines for patients and accelerate drug development and manufacturing.

Contact Information

Website
www.selexis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Route de la Galaise 36
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
JSR
Vertical(s)
Life Sciences
Corporate Office
  • Route de la Galaise 36
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Selexis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Jun-2017 Completed Startup
6. Grant 20-May-2015 Completed Startup
5. Early Stage VC 01-Mar-2004 Completed Startup
4. Early Stage VC 01-Feb-2003 Completed Startup
3. Seed Round 01-Mar-2001 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Mar-2001 Completed Startup
To view Selexis’s complete valuation and funding history, request access »

Selexis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a life science company intended to develop cell line generation technologies that improve the expression of
Biotechnology
Geneva, Switzerland
24 As of 2016

Cambridge, United Kingdom
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Selexis Competitors (60)

One of Selexis’s 60 competitors is Crescendo Biologics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crescendo Biologics Venture Capital-Backed Cambridge, United Kingdom
MiNA Therapeutics Venture Capital-Backed London, United Kingdom
Akari Therapeutics Formerly VC-backed London, United Kingdom
Memo Therapeutics Formerly VC-backed Zurich, Switzerland
Apellis Pharmaceuticals Formerly VC-backed Waltham, MA
You’re viewing 5 of 60 competitors. Get the full list »

Selexis Patents

  • 120

    Total Documents Applications and Grants

  • Total Patents Families

  • 49

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Selexis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026162509-A1 Integration regions and uses thereof Pending 28-Jan-2025
EP-4253523-A1 Automated incubator shaker compartment Inactive 01-Apr-2022
EP-4504898-A1 Automated orbital incubator shaker compartment Pending 01-Apr-2022
US-20250230394-A1 Automated orbital incubator shaker compartment Pending 01-Apr-2022
WO-2023187011-A1 Automated orbital incubator shaker compartment Inactive 01-Apr-2022 C12M27/16
To view Selexis’s complete patent history, request access »

Selexis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selexis Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Commission pour la Technologie et l'Innovation Corporation Minority
Eurostars Other Minority
Fongit Accelerator/Incubator
Fongit Seed Invest Venture Capital Minority
StartAngels Network Angel Group Minority
To view Selexis’s complete investors history, request access »

Ready to get started?

Request a free trial

Selexis FAQs

  • When was Selexis founded?

    Selexis was founded in 2001.

  • Where is Selexis headquartered?

    Selexis is headquartered in Geneva, Switzerland.

  • What is the size of Selexis?

    Selexis has 24 total employees.

  • What industry is Selexis in?

    Selexis’s primary industry is Biotechnology.

  • Is Selexis a private or public company?

    Selexis is a Private company.

  • What is Selexis’s current revenue?

    The current revenue for Selexis is .

  • Who are Selexis’s investors?

    Commission pour la Technologie et l'Innovation, Eurostars, Fongit, Fongit Seed Invest, and StartAngels Network have invested in Selexis.

  • Who are Selexis’s competitors?

    Crescendo Biologics, MiNA Therapeutics, Akari Therapeutics, Memo Therapeutics, and Apellis Pharmaceuticals are some of the 60 competitors of Selexis.

  • When was Selexis acquired?

    Selexis was acquired on 07-Jun-2017.

  • Who acquired Selexis?

    Selexis was acquired by JSR and JSR Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process